Choosing an SPPS resin means choosing a matrix and a linker together. This guide covers the practical chemistry of polystyrene, polyamide, and PS-PEG supports, including mesh size, loading, and swelling behavior; the standard swelling and washing protocols for Fmoc/tBu assembly; and exact…
Select a resin for Fmoc/tBu synthesis as a two-part system: the polymer matrix that gives the beads their mechanical and swelling properties, and the linker that carries the first amino acid. For routine peptides, use cross-linked polystyrene PS at 200-400 mesh with a loading of 0.5-0.8 mmol/g, swell the beads in DCM for 20-30 minutes, and anchor the first residue through a linker matched to the C-terminus you need: an amino resin for peptide amides, a hydroxyl resin such as Wang for peptide acids, and a trityl resin for acid-sensitive or cyclization-prone sequences. The sections that follow give the chemistry behind those choices and the exact swelling, washing, and anchoring procedures.
Bruce Merrifield's introduction of solid-phase peptide synthesis transformed peptide preparation by removing the difficult purifications that dominate solution-phase synthesis. Because the growing chain is attached to an insoluble bead, coupling can be driven with excess activated amino acids, and the excess reagents and by-products are removed by simple filtration and washing. The chain is assembled stepwise from the C-terminus to the N-terminus, with the first residue joined to the resin through an ester bond, which yields a peptide acid after cleavage, or an amide bond, which yields a peptide amide. Assembly proceeds by repeated cycles of coupling, washing, deprotection, and re-coupling, and ends with a single cleavage from the resin that removes side-chain protecting groups at the same time.
Two protecting-group strategies dominate. Side chains carry permanent protecting groups, while the temporary N-terminal protection uses carbamate-type groups that are removable under mild conditions, which avoids racemization. In the Boc/Bzl strategy, deprotection requires strong acid, typically TFA, repeated at every cycle, and that can damage acid-sensitive sequences. In the Fmoc/tBu strategy, the Fmoc group is base-labile and the tBu side-chain groups are weak-acid-labile, so the final TFA cleavage releases the peptide and removes side-chain protection in one operation. Fmoc is generally preferred for routine synthesis.
A resin system is a matrix plus a linker, and the word "resin" is loose shorthand for the whole system. More than a hundred commercial resins are available, and some share the same linker on different matrices, so specifications should be read as matrix properties, linker chemistry, and loading separately. Cross-linked PS is the workhorse matrix: 200-400 mesh beads are about 50 μm in diameter, carry loadings of 0.5-0.8 mmol/g, and swell well in DMF and DCM. For peptides longer than 25 amino acids, or for difficult sequences, use a lower-loading PS resin of 0.1-0.2 mmol/g. Fewer chains per bead reduce steric crowding, and the more open matrix that accompanies low loading gives activated amino acids better access to the linkers. Polyamide and polystyrene-polyethylene glycol PS-PEG composites are more hydrophilic than PS, generally have lower loading capacities, and are alternatives for complex sequences and large peptides. PS suits routine synthesis; PS-PEG helps with long peptides; polyamide covers specialized applications.
Swelling is not optional, and the reason is geometric. About 99% of coupling sites lie inside the beads rather than on their surface, and before use the polymer chains can be collapsed or entangled, blocking access to the linkers. The analogy commonly used is textile dyeing: the fiber must be swollen before the dye can penetrate. The standard procedure is to immerse the resin in DCM, mix gently with a PTFE stirring rod, let it stand 20-30 minutes, and remove the solvent by vacuum filtration. DCM gives the best swelling of PS, but DMF or NMP is preferred during coupling because these solvents dissolve the reactants better. The practical rule is to swell in DCM and couple in DMF or NMP.
Alcohols and water are unsuitable for swelling PS resins. Methanol or isopropanol shrink the beads, which is exploited deliberately during washing: shrinking expels trapped excess reactants from the bead interior. After an alcohol wash, the beads must be reswollen in DCM and DMF before synthesis continues.
The reactor should match the resin quantity. A standard glass vessel with a PTFE or glass frit covers most bench syntheses. A small reactor of 5 cm x 2 cm takes a maximum of 0.5 g of resin with a working volume of 10 mL. A medium reactor of 11 cm x 2.6 cm takes up to 2 g in 40 mL. A large reactor of 15 cm x 3.4 cm takes up to 4 g in 90 mL. Mixing must be gentle. SPPS kinetics are governed mainly by diffusion, so vigorous stirring is unnecessary and can break fragile resin beads. A rotary evaporator rotor, or a rocking or vortex-like motion, is enough to keep the beads bathed in solution while diffusion carries the reagents inward.
Washing removes the soluble by-products and the excess of the last reagent. The recommended sequence is DMF washes, then methanol washes, then DCM washes, then DMF washes, with each solvent repeated one to two times. During the DMF washes the resin stands briefly, on the order of 10 seconds, before the solvent is removed by filtration; the short stand lets the solvent equilibrate with the bead interior without the abrasion of continuous agitation.
Each solvent in the sequence has a job. DMF carries away the soluble by-products of coupling and deprotection. Methanol shrinks the beads and displaces trapped excess reagent from the interior. DCM reswells them, and the final DMF wash conditions the resin for the next reaction. The sequence should be followed even when the synthesis appears clean, because truncated products often originate in the bead interior, where washing is weakest, and because the beads must be fully reswollen before the next coupling.
If the target has a C-terminal amide, the resin presents amino groups. Amide-producing resins of this kind are often supplied with the amino groups Fmoc-protected, so the first operation is a deprotection identical in chemistry to the deprotection used later in each cycle. The first amino acid then forms an amide bond to the linker, and cleavage with TFA releases the peptide with the amide intact.
Because amino groups are strong nucleophiles, amide anchoring is the more forgiving of the two anchoring chemistries. The known failure mode is steric: amino acids with substantial hindrance at the C-terminus may couple incompletely to amide resins and may need a second coupling. Confirm that first-residue loading reached an acceptable level before continuing, and plan the second coupling where the C-terminal residue is bulky.
Peptide acids require an ester bond to a hydroxyl linker, and esterification is the harder operation. Hydroxyl groups are less nucleophilic than amino groups, the anchoring reaction is slower, and it can be accompanied by epimerization, dipeptide formation, and variable substitution levels. Ester anchoring under Fmoc/tBu conditions must be performed anhydrously; free water hydrolyzes the activated species before it reaches the hydroxyl, and amino acid samples that have absorbed moisture should be dried beforehand. Preloaded linkers, with the first residue already attached, are available on PS, polyamide, and PS-PEG matrices, and any in-house anchoring must meet the same anhydrous and quality-control standards.
Wang resin is a less sterically hindered hydroxyl resin that forms ester bonds readily, typically through the symmetrical anhydride method. A standard loading procedure uses 10.0 equivalents of Fmoc amino acid and 5.0 equivalents of DIC in DCM at 0°C, with 10 minutes of activation, DMAP/DMF catalysis, 1 hour of stirring, washing, and 18 hours of vacuum drying. Loading is then checked by Fmoc release assay: a weighed sample is treated with base, and the released Fmoc chromophore is quantified spectrophotometrically. If the measured loading is below 70% of the expected value, repeat the esterification with fresh reagents; difficult amino acid derivatives may require up to three cycles before the loading is acceptable.
After anchoring, unreacted hydroxyl groups should be capped. The capping procedure uses 5 equivalents of benzoic anhydride or acetic anhydride and 1 equivalent of pyridine in DMF for 30 minutes. Free hydroxyls on the resin would otherwise initiate new chains during assembly, producing deletion peptides that are extremely difficult to separate from the target.
Trityl-series resins sit at the other end of the lability scale. They are highly acid-labile, so the peptide can be cleaved under very mild acidic conditions, which suits acid-sensitive sequences. Their steric bulk also suppresses diketopiperazine formation, the intramolecular cyclization that can strip the first two residues off the resin when the C-terminal residue is proline or glycine. For these two reasons, trityl resins are recommended for peptides with C-terminal proline or glycine.
Trityl resins are typically supplied as chlorotrityl resin or trityl alcohol precursors. The common chlorotrityl coupling procedure: 1 g of resin with a chloride loading of 1.0-2.0 mmol/g is treated with 3 equivalents of Fmoc amino acid and 7.5 equivalents of DIPEA in anhydrous DCM at room temperature for 30-60 minutes. The resin is washed with DMF two to three times, and residual chloride groups are capped with 10 mL of DCM/MeOH/DIPEA for 15 minutes, followed by three final washes with DMF and DCM. The amino acid to DIPEA ratio matters, and the methanol quench matters more: it converts unreacted trityl chloride to the methyl ester, capping the site and ensuring single-site attachment, so that each trityl group carries exactly one amino acid. Chlorotrityl resins are moisture-sensitive; water converts the chloride to the alcohol and lowers the effective loading, so anhydrous handling is required at every step.
The protocols above rest on decades of accumulated laboratory practice and supplier documentation, not on a clinical-trial evidence base. Among the registered studies retrieved for this article, none compares SPPS resins, linkers, swelling times, or anchoring procedures. The nearest records concern peptide and protein therapeutics made by other routes. NCT04717154, a completed phase 2 trial of ipilimumab with nivolumab in molecularly selected castration-resistant prostate cancer n=69 , and NCT04145349, a completed phase 1/2 study of ramucirumab in desmoplastic small round cell tumor n=30 , test those drugs. NCT05537220, a phase 3 trial of oral N-acetylcysteine for retinitis pigmentosa n=485, active but not recruiting , tests N-acetylcysteine. NCT02137239 is a completed phase 2 regimen optimization study in kidney transplantation n=58 , and NCT07051330 is a recruiting personalized training study n=1500 . This absence is not an oversight; it reflects how the field operates. Bench-scale SPPS decisions are validated locally, by loading assays and by the quality of the crude product, not by registration-level clinical evidence.
That leaves several questions genuinely open. The swelling and washing procedures above are written for PS matrices; how they should be adapted for polyamide or PS-PEG resins is not quantitatively settled, and the more hydrophilic matrices will need different solvents and possibly shorter equilibration times. The exact steps of the Fmoc release assay, including the base, solvent, sampling, and quantification wavelength, vary between laboratories, and the 70% repeat threshold is a practical rule of thumb, not a statistically derived cutoff. The choice between Wang, trityl, and other linkers is guided by the C-terminal residue, the desired cleavage conditions, and the risk of diketopiperazine formation, but no decision algorithm covers every sequence. The criteria for repeating a coupling during chain elongation, beyond an obviously low loading or a hindered C-terminal residue, remain a matter of judgment. For a researcher setting up Fmoc SPPS, the practical answer is to choose the matrix and linker as one system, verify the loading empirically, and treat every swelling and washing step as part of the chemistry rather than as housekeeping.
Practical caveats worth keeping in view for a first synthesis:
Related reading: Enzymatic Routes to Oligopeptide Synthesis: A Technical Overview, Six biocatalytic strategies for enzymatic oligopeptide synthesis, Peptide-Receptor Systems for Tumor Imaging: A Field Guide, How cyclic peptides cross lipid membranes: a four-step mechanism.